Nanocarriers for effective topical delivery of anti-infectives

Current Nanoscience

Volumn 8, Issue 4, 2012, Pages 491-503

  Prabhu, Priyanka ^a   Patravale, Vandana ^a   Joshi, Medha ^a,b  

^a INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b MIDWESTERN UNIVERSITY   (United States)

Author keywords

Anti infective; Liposomes; Microemulsions; Nitric oxide; Silver nanoparticles; Solid lipid nanoparticles; Topical delivery

Indexed keywords

ANTI-INFECTIVE; ANTI-INFECTIVES; ANTI-MICROBIAL ACTIVITY; ANTIBACTERIALS; ANTIFUNGALS; ANTIVIRALS; BACTERIAL STRAINS; DELIVERY SYSTEMS; HOSPITAL ADMISSIONS; HUMAN SKIN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; NANOCARRIERS; PATHOGENIC MICROBES; SILVER NANOPARTICLES; SKIN INFECTION; SKIN LAYER; SOLID LIPID NANOPARTICLE (SLN); THERAPEUTIC EFFICACY; TOPICAL DELIVERY; VANCOMYCIN-RESISTANT ENTEROCOCCI;

ARSENALS; BACILLI; DRUG DOSAGE; ENZYME INHIBITION; LIPOSOMES; MICROEMULSIONS; NANOPARTICLES; NITRIC OXIDE; SKIN; VIRUSES;

SILVER;

ACICLOVIR; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIPARASITIC AGENT; ANTIVIRUS AGENT; CICLOPIROXOLAMINE; ECONAZOLE; FLUCONAZOLE; GRISEOFULVIN; KETOCONAZOLE; LAURIC ACID; MICONAZOLE NITRATE; NANOCARRIER; NANOFIBER; NITRIC OXIDE; PAROMOMYCIN; PENCICLOVIR; PENICILLIN G; PSEUDOMONIC ACID; SILVER NANOPARTICLE;

ARTICLE; BACTERIAL SKIN DISEASE; CANDIDIASIS; CARBUNCLE; CELLULITIS; CHICKENPOX; DERMATOMYCOSIS; DERMATOPHYTOSIS; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG PENETRATION; DRUG SOLUBILITY; ECTHYMA; ERYSIPELAS; ERYTHEMA INFECTIOSUM; EXANTHEMA SUBITUM; FOLLICULITIS; FUNGAL SKIN INFECTION; FURUNCULOSIS; HAEMOPHILUS INFLUENZAE; HAND FOOT AND MOUTH DISEASE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN HERPESVIRUS 6; IMPETIGO; MICROEMULSION; MOLLUSCUM CONTAGIOSUM; NONHUMAN; PARASITIC SKIN INFECTION; PATIENT COMPLIANCE; PRIORITY JOURNAL; SKIN INFECTION; SKIN LEISHMANIASIS; STAPHYLOCOCCUS; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PNEUMONIAE; TINEA VERSICOLOR; TRICHOPHYTON RUBRUM; VERRUCA VULGARIS; VIRAL SKIN DISEASE;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECALIS; FUNGI; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 84863942100     PISSN: 15734137     EISSN: 18756786     Source Type: Journal    
DOI: 10.2174/157341312801784221     Document Type: Article

References (100)

1. Alsterholm, M.; Karami, N.; Faergemann, J. Antimicrobial Activity of Topical Skin Pharmaceuticals-An In vitro Study. Acta. Derm. Venereol., 2010, 90(3), 239-245.
2. Chiller, K.; Selkin, B.A.; Murakawa, G.J. Skin Microflora and Bacterial Infections of the Skin. J. Investig. Dermatol. Symp. Proc., 2001, 6(3), 170-174.
3. Zeligman, I. The Skin as a Physiologic Organ. J. Natl. Med. Assoc., 1961, 53(2), 148-150.
4. Thormar, H.; Hilmarsson, H. The role of microbicidal lipids in host defense against pathogens and their potential as therapeutic agents. Chem. Phys. Lipids, 2007, 150(1), 1-11.
5. Nakatsuji, T.; Kao, M.C.; Fang, J-Y.; Zouboulis, C. C; Zhang, L.; Gallo, R.L.; Huang, C-M. Antimicrobial Property of Lauric Acid Against Propionibacterium acnes: Its Therapeutic Potential for Inflammatory Acne Vulgaris. J. Invest. Dermatol., 2009, 129(10), 2480-2488.
6. Drake, D.R.; Brogden, K.A.; Dawson, D.V.; Wertz, P.W. Antimicrobial lipids at the skin surface. J. Lip. Res., 2008, 49(1), 4-11.
7. Török, M.E.; Conlon, C.P.; Skin and soft tissue infections. Medicine, 2009, 37(11), 603-609.
8. Ruocco, E.; Donnarumma, G.; Baroni, A.; Tufano, M.A. Bacterial and Viral Skin Diseases. Dermatol. Clin., 2007, 25(4), 663-676.
9. Török, E.; Conlon, C.P. Skin and soft tissue infections. Medicine, 2005, 33(4), 84-88.
10. Bhagavatula, M.; Powell, C. Common superficial skin infections and infestations. Paediatr. Child Health, 2011, 21(3), 132-136.
11. Kaur, I.P.; Kakkar, S. Topical delivery of antifungal agents. Expert Opin. Drug Deliv., 2010, 7(11), 1303-1327.
12. Pearson, R.D.; Jeronimo, S.M.B.; Sousa, A. de Q. Leishmaniasis. In: Essentials of Tropical Infectious Diseases, Guerrant, R.L.; Walker, D.H., Weller, P.F.; Ed.; Churchill Livingstone: Philadelphia, 2001; pp. 372-379.
13. Wittner, M.; Tanowitz, H.B. Other cestode infections. In: Essentials of Tropical Infectious Diseases, Guerrant, R.L.; Walker, D.H., Weller, P.F.; Ed.; Churchill Livingstone: N.Y.; 2001; pp. 490-491.
14. El Mahrab Robert, M.; Kalia, Y.N. New Developments in Topical Antifungal Therapy. Am. J. Drug Deliv., 2006, 4(4), 231-247.
15. Sanna, V.; Gavini, E.; Cossu, M.; Rassu, G.; Giunchedi, P. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies. J. Pharm. Pharmacol., 2007, 59(8), 1057-1064.
16. Liu, J.; Hu, W.; Chen, H.; Ni, Q.; Xu, H.; Yang, X. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int. J. Pharm., 2007, 328(2), 191-195.
17. Shah, K.A.; Date, A.A.; Joshi, M.D.; Patravale, V.B. Solid lipid nanoparticles (SLN) of tretinoin: Potential in topical delivery. Int. J. Pharm., 2007, 345(1-2), 163-171.
18. Pattani, A.S.; Mandawgade, S.D.; Patravale, V.B. Development and comparative anti-microbial evaluation of lipid nanoparticles and nanoemulsion of Polymyxin B. J. Nanosci. Nanotechnol., 2006, 6(9-10), 2986-2990.
19. Joshi, M.D.; Patravale V.B. Nanostructured lipid carrier (NLC) based gel of celecoxib. Int. J. Pharm., 2008, 346(1-2), 124-132.
20. Briones, E.; Colino, C.I.; Lanao, J.M. Delivery systems to increase the selectivity of antibiotics in phagocytic cells. J. Control Release, 2008, 125(3), 210-227.
21. Grampurohit, N.; Ravikumar, P.; Mallya, R. Microemulsions for Topical Use-A Review. Int. J. Pharm. Educ. Res., 2011, 45(1), 100-107.
22. Patel, M.R.; Patel, R.B.; Parikh J.R.; Bhatt K.K.; Solanki, A.B. Investigating the effect of vehicle on in vitro skin permeation of ketoconazole applied in O/W microemulsions. Acta Pharm. Sci., 2010, 52(1), 65-77.
23. Patel, M.R.; Patel, R.B.; Parikh J.R.; Solanki A.B.; Patel B.G. Effect of Formulation Components on the In vitro Permeation of Microemulsion Drug Delivery System of Fluconazole. AAPS Pharm. Sci. Tech., 2009, 10(3), 917-923.
24. Ayub, A.C.; Gomes, A.D.M.; Lima, M.V. C; Vianna-Soares C.D.; Ferreira, L.A.M. Topical Delivery of Fluconazole: In vitro Skin Penetration and Permeation Using Emulsions as Dosage Forms. Drug Dev. Ind. Pharm., 2007, 33(3), 273-280.
25. Piemi, M.P.Y.; Korner, D.; Benita, S.; Marty, J-P. Positively and negatively charged submicron emulsions for enhanced topical delivery of antifungal drugs. J. Control Release, 1999, 58(2), 177-187.
26. Peira, E.; Carlotti M.E.; Trotta, C.; Cavalli, R.; Trotta, M. Positively charged microemulsions for topical application. Int. J. Pharm., 2008, 346(1-2), 119-123.
27. Lee, E-A.; Balakrishnan, P.; Song, C.K.; Choi, J-H.; Noh, G.Y.; Park, C-G.; Choi, A-J.; Chung, S-J.; Shim, C-K.; Kim, D-D. Microemulsion-based Hydrogel Formulation of Itraconazole for Topical Delivery. J. Pharm. Invest., 2010, 40(5), 305-311.
28. El Laithy, H.M.; El-Shaboury, K.M.F. The Development of Cutina Lipogels and Gel Microemulsion for Topical Administration of Fluconazole. AAPS Pharm. Sci. Tech., 2002, 3(4), 77-85.
29. Salerno, C.; Carlucci, A.M.; Bregni, C. Study of In vitro Drug Release and Percutaneous Absorption of Fluconazole from Topical Dosage Forms. AAPS Pharm. Sci Tech., 2010, 11(2), 986-993.
30. Shishu, Rajan, S.; Kamalpreet, Development of Novel Microemulsion-Based Topical Formulations of Acyclovir for the Treatment of Cutaneous Herpetic Infections. AAPS Pharm. Sci. Tech., 2009, 10(2), 559-565.
31. Zhu, W.; Yu, A.; Wang, W.; Dong, R.; Wu, J.; Zhai, G. Formulation design of microemulsion for dermal delivery of penciclovir. Int. J. Pharm., 2008, 360(1-2), 184-190.
32. Yu, A.; Guo, C.; Zhou Y.; Cao, F.; Zhu, W.; Sun, M.; Zhai, G. Skin irritation and the inhibition effect on HSV-1 in vivo of penciclovir-loaded microemulsion. Int. Immunopharmacol., 2010, 10(10), 1305-1309.
33. Zhu, W.; Guo, C.; Yu, A.; Gao, Y.; Cao, F.; Zhai, G. Microemulsion-based hydrogel formulation of penciclovir for topical delivery. Int. J. Pharm., 2009, 378(1-2), 152-158.
34. Dai, T.; Huang, Y-Y.; Sharma, S.K.; Hashmi, J.T.; Kurup, D.B.; Hamblin, M.R. Topical Antimicrobials for Burn Wound Infections. Recent Patents Anti-Infect Drug Discov., 2010, 5(2), 124-151.
35. Hemmila, M.R.; Mattar, A.; Taddonio, M.A.; Arbabi, S.; Hamouda, T.; Ward, P.A.; Wang, S.C.; Baker, J.R. Topical nanoemulsion therapy reduces bacterial wound infection and inflammation after burn injury. Surgery, 2010, 148(3), 499-509.
36. Greenhalgh, K.; Turos, E. In vivo studies of polyacrylate nanoparticle emulsions for topical and systemic applications. Nanomedicine, 2009, 5(1), 46-54.
37. Ning, M., Gu, Z.; Pan, H.; Yu, H.; Xiao, K. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antifungal drug clotrimazole. Indian J. Exp. Biol., 2005, 43(2), 150-157.
38. Coderch, L.; Fonollosa, J.; De Pera, M.; Estelrich, J.; De La Maza, A.; Parra, J.L. Influence of cholesterol on liposome fluidity by EPR. Relationship with percutaneous absorption. J. Control Release, 2000, 68(1), 85-95.
39. Verma, D.D.; Verma, S.; Blume, G.; Fahr, A. Particle size of liposomes influences dermal delivery of substances into skin. Int. J. Pharm., 2003, 258(1-2), 141-151.
40. Ogiso, T.; Yamaguchi, T.; Iwaki, M.; Tanino, T.; Miyake, Y. Effect of positively and negatively charged liposomes on skin permeation of drugs. J. Drug Target, 2001, 9(1), 49-59.
41. Fang, J-Y.; Hwang, T-L.; Huang, Y-L. Liposomes as Vehicles for Enhancing Drug Delivery via Skin Routes. Curr. Nanosci., 2006, 2(1), 55-70.
42. Agarwal, R.; Katare, O. P. Preparation and in vitro evaluation of miconazole nitrate-loaded topical liposomes. Pharm. Technol., 2002, 26, 48-60.
43. Gupta, M.; Goyal, A.K.; Paliwal, S. R.; Paliwal, R.; Mishra, N.; Vaidya, B.; Dube, D.; Jain, S.K.; Vyas, S.P. Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis. J. Liposome Res., 2010, 20(4), 341-350.
44. Shaikh, K.S.; Pawar, A.P. Liposomal delivery enhances cutaneous availability of ciclopirox olamine. Latin Am. J. Pharm., 2010, 29(5), 763-770.
45. Bhalaria, M.K.; Naik, S.; Misra, A.N. Ethosomes: A novel delivery system for antifungal drugs in the treatment of topical fungal diseases. Indian J. Exp. Biol., 2009, 47(5), 368-375.
46. Kassem, M.A.; Esmat, S.; Bendas, E.R.; El-Komy, M.H. Efficacy of topical griseofulvin in treatment of Tinea corporis. Mycoses, 2006, 49(3), 232-235.
47. Weiner, N.; Williams, N.; Birch, G.; Ramachandran, C.; Shipman, C.; Flynn, G. Topical delivery of liposomally encapsulated interferon evaluated in a cutaneous herpes guinea pig model. Antimicrob. Agents Chemother., 1989, 33(8), 1217-1221.
48. Piret, J.; Gourde, P.; Cormier, H.; Desormeaux, A.; Beauchamp, D.; Tremblay, M. J.; Juhasz, J.; Bergeron, M.G. Efficacy of gel formulations containing free and liposomal foscarnet in a murine model of cutaneous HSV-1 infection. J. Liposome Res., 1999, 9(2), 181-198.
49. Yang, D.; Pornpattananangkul, D.; Nakatsuji, T.; Chan, M.; Carson, D.; Huang, C-M.; Zhang, L. The Antimicrobial Activity of Liposomal Lauric Acids against Propionibacterium acnes. Biomaterials, 2009, 30(30), 6035-6040.
50. Jones, M.N.; Kaszuba, M.; Hill, K.J.; Song, Y.H.; Creeth, J.E. The use of phospholipid liposomes for targeting to oral and skin-associated bacteria. J. Drug Target, 1994, 2(5), 381-389.
51. Yardley, V.; Croft, S.L. Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis. Antimicrob. Agents Chemother., 1997, 41(4), 752-756.
52. Jaafari, M. R.; Bavarsad, N.; Bazzaz, B. S.; Samiei, A.; Soroush, D.; Ghorbani, S.; Heravi, M. M.; Khamesipour, A. Effect of topical liposomes containing paromomycin sulfate in the course of Leishmania major infection in susceptible BALB/c mice. Antimicrob. Agents Chemother., 2009, 53(6), 2259-2265.
53. Panosian, C.B.; Barza, M.; Szoka, F.; Wyler, D.J. Treatment of experimental cutaneous leishmaniasis with liposome-intercalated amphotericin B. Antimicrob. Agents Chemother., 1984, 25(5), 655-656.
54. Barakat, H.S.; Darwish, I.A.; El-Khordagui, L.K.; Khalafallah, N.M. Development of Naftifine Hydrochloride Alcohol-Free Niosome Gel. Drug. Dev. Ind. Pharm., 2009, 35(5), 631-637.
55. Li-Ping, L.; Wei, M.; Yuan-Chu, A. Study on in vitro percutaneous permeabilities and antibacterial activities of clotrimazole-encapsulated ethosomes and liposomes. Chin. Pharm. J., 2009, 44, 278-282.
56. Godin, B.; Touitou, E. Erythromycin ethosomal systems: Physicochemical characterization and enhanced antibacterial activity. Curr. Drug. Deliv., 2005, 2(3), 269-275.
57. Godin, B.; Touitou, E.; Rubinstein, E.; Athamna, A.; Athamna, M. A new approach for treatment of deep skin infections by an ethosomal antibiotic preparation: an in vivo study. J. Antimicrob. Ther., 2005, 55(6), 989-994.
58. Godin, B.; Touitou, E. Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. J. Control Release, 2004, 94(2-3), 365-379.
59. Horwitz E, Pisanty S, Czerninski R, Helsar, M.; Eliav, E.; Touitou, E. A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent Herpes labialis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 1999, 87(6), 700-705.
60. Pardeike, J.; Hommoss, A.; Müller, R.H. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int. J. Pharm., 2009, 366(1-2), 170-184.
61. Souto, E.B.; Wissing, S.A.; Barbosa, C.M.; Muller, R.H. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int. J. Pharm., 2004, 278(1), 71-77.
62. Lv, Q.; Yu, A.; Xi, Y.; Li, H.; Song, Z.; Cui, J.; Cao, F.; Zhai, G. Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. Int. J. Pharm., 2009, 372(1-2), 191-198.
63. Muller, R.H.; Radtke, M.; Wissing, S.A. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev., 2002, 54(1), S131-S155.
64. Souto, E.B.; Muller, R.H. Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization. J. Microencapsul., 2006, 23(4), 377-388.
65. Souto, E.B.; Muller, R.H. Rheological and in vitro release behaviour of clotrimazole-containing aqueous SLN dispersions and commercial creams. Pharmazie, 2007, 62(7), 505-509.
66. Jain, S.; Jain, S.; Khare, P.; Gulbake, A.; Bansal, D.; Jain, S.K. Design and development of solid lipid nanoparticles for topical delivery of an anti-fungal agent. Drug Deliv., 2010, 17(6), 443-451.
67. Bhalekar, M.R.; Pokharkar, V.; Madgulkar, A.; Patil, N.; Patil, N. Preparation and Evaluation of Miconazole Nitrate-Loaded Solid Lipid Nanoparticles for Topical Delivery. AAPS Pharm. Sci. Tech., 2009, 10(1), 289-296.
68. Garg, A.; Singh, S. Enhancement in Antifungal Activity of Eugenol in Immunosuppressed Rats through Lipid Nanocarriers. Colloids Surf B Biointerfaces, 2011, 87(2), 280-288.
69. Chen, H.; Chang, X.; Du, D.; Liu, W.; Liu, J.; Weng, T.; Yang, Y.; Xu, H.; Yang, X. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J. Control Release, 2006, 110(2), 296-306.
70. Lai, F.; Sinico, C.; De Logu, A.; Zaru, M.; Müller, R.H.; Fadda, A.M. SLN as a topical delivery system for Artemisia arborescens essential oil: In vitro antiviral activity and skin permeation study. Int. J. Nanomedicine, 2007, 2(3), 419-425.
71. Makhmal Zadeh, B.S.; Barati, N.; Hassani, M.H.; Rahim, F. Development of Solid lipid nanoparticles as Eschar delivery system for Nitrofurazone Using Taguchi Design Approach, Int. J. Res. Pharm. Sci., 2010, 1(4), 466-472.
72. Rai, M.; Yadav, A.; Gade, A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol. Adv., 2009, 27(1), 76-83.
73. Atiyeh, B.S.; Costagliola, M.; Hayek, S.N.; Dibo, S.A. Effect of silver on burn wound infection control and healing: Review of the literature. Burns, 2007, 33(2), 139-148.
74. Kim; K-J.; Sung, W.S.; Moon, S-K.; Choi, J-S.; Kim, J.G.; Lee, D.G. Antifungal Effect of Silver Nanoparticles on Dermatophytes. J. Microbiol. Biotechnol., 2008, 18(8), 1482-1484.
75. Jaiswal, S.; Duffy, B.; Jaiswal, A.K.; Stobie, N.; McHale, P. Enhancement of the antibacterial properties of silver nanoparticles using beta-cyclodextrin as a capping agent. Int. J. Antimicrob. Agents, 2010, 36(3), 280-283.
76. Tripathi, R.M.; Saxena, A.; Gupta, N.; Kapoor, H.; Singh, R.P. High antibacterial activity of silver nanoballs against E. coli MTCC 1302, S. typhimurium MTCC 1254, B. subtilis MTCC 1133 and P. aeruginosa MTCC 2295. Digest J. Nanomater. Biostruct., 2010, 5(2), 323-330.
77. Jain, J.; Arora, S.; Rajwade J.M.; Omray P.; Khandelwal, S.; Paknikar K.M. Silver Nanoparticles in Therapeutics: Development of an Antimicrobial Gel Formulation for Topical Use. Mol. Pharm., 2009, 6(5), 1388-1401.
78. Raffi, M.; Hussain, F.; Bhatti, T.M.; Akhter, J.I.; Hameed, A.; Hasan, M.M. Antibacterial Characterization of Silver Nanoparticles against E. Coli ATCC-15224. J. Mater. Sci. Technol., 2008, 24(2), 192-196.
79. Kim, Soo-Hwan, Lee, H-S.; Ryu, D-S.; Choi, S-J.; Lee, D-S.; Antibacterial Activity of Silver-nanoparticles Against Staphylococcus aureus and Escherichia coli. Korean J. Microbiol. Biotechnol., 2011, 39(1), 77-85.
80. Larese, F.F.; D'Agostin, F.; Crosera, M.; Adami, G.; Renzi, N.; Bovenzi, M.; Maina, G. Human skin penetration of silver nanoparticles through intact and damaged skin. Toxicology, 2009, 255(1-2), 33-37.
81. Englander, L.; Friedman, A. Nitric Oxide Nanoparticle Technology: A Novel Antimicrobial Agent in the Context of Current Treatment of Skin and Soft Tissue Infection. J. Clin. Aesthetic Dermatol., 2010, 3(6), 45-50.
82. Friedman, A.J.; Han, G.; Navati M.S.; Chacko, M.; Gunther, L.; Alfieri, A.; Friedman, J.M. Sustained release nitric oxide releasing nanoparticles: characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites. Nitric Oxide, 2008, 19(1), 12-20.
83. Martinez, L.R.; Han, G.; Chacko, M.; Mihu, M.R.; Jacobson, M.; Gialanella, P.; Friedman, A.J.; Nosanchuk, J.D.; Friedman, J.M. Antimicrobial and Healing Efficacy of Sustained Release Nitric Oxide Nanoparticles Against Staphylococcus aureus Skin Infection. J. Invest. Dermatol., 2009, 129(10), 2463-2469.
84. Mihu, M.R.; Sandkovsky, U.; Han, G.; Friedman, J.M.; Nosanchuk, J.D.; Martinez, L.R. Nitric oxide releasing nanoparticles are therapeutic for Acinetobacter baumannii wound infections. Virulence, 2010, 1(2), 62-67.
85. Hetrick, E.M.; Shin, J.H.; Paul, H.S.; Schoenfisch, M.H. Anti-Biofilm Efficacy of Nitric Oxide-Releasing Silica Nanoparticles. Biomaterials, 2009, 30(14), 2782-2789.
86. Han, G.; Martinez, L.R.; Mihu, M.R.; Friedman, A.J.; Friedman, J.M.; Nosanchuk, J.D. Nitric Oxide Releasing Nanoparticles Are Therapeutic for Staphylococcus aureus Abscesses in a Murine Model of Infection. PLoS ONE, 2009, 4(11), 1-7.
87. Friedman, A.; Blecher, K.; Sanchez, D.; Tuckman-Vernon, C.; Gialanella, P.; Friedman, J.M.; Martinez, L.R.; Nosanchuk, J.D. Susceptibility of Grampositive and-negative bacteria to novel nitric oxide-releasing nanoparticle technology. Virulence, 2011, 2(3), 217-221.
88. Kedar, U.; Phutane, P.; Shidhaye, S.; Kadam, V. Advances in polymeric micelles for drug delivery and tumor targeting, Nanomedicine, 2010, 6(6), 714-729.
89. Bachhav, Y.G.; Mondon, K.; Kalia, Y.N.; Gurny, R.; Möller, M. Novel micelle formulations to increase cutaneous bioavailability of azole antifungals. J. Control Release, 2011, 153(2), 126-132.
90. Chiappetta, D.A.; Degrossi, J.; Teves, S.; D'Aquino, M.; Bregni, C.; Sosnik, A. Triclosan-loaded poloxamine micelles for enhanced topical antibacterial activity against biofilm. Eur. J. Pharm. Biopharm., 2008, 69(2), 535-545.
91. Sharma, R.; Pathak, K. Polymeric nanosponges as an alternative carrier for improved retention of econazole nitrate onto the skin through topical hydrogel formulation. Pharm. Dev. Technol., 2011, 16(4), 367-376.
92. Heunis, T.D.J.; Dicks, L.M.T. Nanofibers Offer Alternative Ways to the Treatment of Skin Infections. J. Biomed. Biotech., 2010, 2010, 1-10.
93. Rujitanaroj, P.; Pimpha, N.; Supaphol, P. Wound-dressing materials with antibacterial activity from electrospun gelatin fiber mats containing silver nanoparticles. Polymer, 2008, 49(21), 4723-4732.
94. Hong, K.H.; Park, J.L.; Sul, I.H.; Youk, J.H.; Kang, T.J. Preparation of Antimicrobial Poly(vinyl alcohol) Nanofibers Containing Silver Nanoparticles. J. Polym. Sci. Part B: Polymer Phys., 2006, 44(17), 2468-2474.
95. Son, W.K.; Youk J.H.; Park, W.H. Antimicrobial cellulose acetate nanofibers containing silver nanoparticles. Carbohydr. Polym., 2006, 65(4), 430-434.
96. Dong, G.; Xiao, X.; Liu, X.; Qian, B.; Ma, Z.; Ye, S.; Chen, D.; Qiu, J. Preparation and characterization of Ag nanoparticle embedded polymer electrospun nanofibers. J. Nanopart. Res., 2010, 12(4), 1319-1329.
97. Lochman, P.; Páral, J.; Koí, J. Gentamicin bound to the nanofibre microdispersed oxidized cellulose in the treatment of deep surgical site infections. J. Appl. Biomed., 2011, 9(3), 143-149.
98. Liu, H.; Leonas, K.K.; Zhao, Y. Antimicrobial Properties and Release Profile of Ampicillin from Electrospun Poly (caprolactone) Nanofiber Yarns. J. Eng. Fibers Fabrics, 2010, 5(4), 10-19.
99. Nakonechny, F.; Firer, M. A.; Nitzan, Y.; Nisnevitch, M. Intracellular antimicrobial photodynamic therapy: A novel technique for efficient eradication of pathogenic bacteria. Photochem. Photobiol., 2010, 86(6), 1350-1355.
100. Pornpattananangkul, D.; Zhang, L.; Olson, S.; Aryal, S.; Obonyo, M.; Vecchio, K.; Huang, C.-M.; Zhang, L. Bacterial Toxin-Triggered Drug Release from Gold Nanoparticle-Stabilized Liposomes for the Treatment of Bacterial Infection. J. Am. Chem. Soc., 2011, 133(11), 4132-4139.